Puente et al. summarized that cell signaling targeted therapies (PI3K/AKT, p38, HDAC, and Wnt) and strategies targeting the tumor microenvironment (such as integrin, hypoxia, and angiogenesis) were currently two types of potential therapeutic strategies. The gene discussed is HDAC9; the disease is neoplasm.